---
title: "Crescent Energy | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 1.395 B"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294734670.md"
datetime: "2026-08-03T20:28:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294734670.md)
  - [en](https://longbridge.com/en/news/294734670.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294734670.md)
generator: "portal-rs"
---

# Crescent Energy | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 1.395 B

Revenue: As of FY2026 Q2, the actual value is USD 1.395 B, beating the estimate of USD 1.261 B.

EPS: As of FY2026 Q2, the actual value is USD 1.3.

EBIT: As of FY2026 Q2, the actual value is USD 763.45 M.

The provided reference is a Form 8-K filing by Crescent Energy Company, announcing the release of its financial and operating results for the quarter ended June 30, 2026, on August 3, 2026. However, the actual financial and operational metrics, as well as any forward-looking statements or guidance, are stated to be included in a press release furnished as Exhibit 99.1, which is not provided within the given reference text. Therefore, no specific financial or operational metrics or outlook can be extracted from the provided text.

### Related Stocks

- [CRGY.US](https://longbridge.com/en/quote/CRGY.US.md)

## Related News & Research

- [CRGY: Record cash flow, higher production, and improved cost efficiency drive strong Q2 2026 results](https://longbridge.com/en/news/294735690.md)
- [Neal Dingmann Reiterates Buy on Crescent Energy After Strong Q2 Beat, Robust FCF, and Cautious but Upbeat 2026 Outlook](https://longbridge.com/en/news/294745012.md)
- [Crescent Energy (CRGY) Beat Production Guidance, Is The Upside Already Priced In?](https://longbridge.com/en/news/292516684.md)
- [Crescent Energy (CRGY) Q1 2026 Earnings Transcript](https://longbridge.com/en/news/285241290.md)
- [Neal Dingmann Reiterates Buy on Crescent, Citing Record FCF Potential, Permian Efficiency Gains, and 23% Upside Fair Value](https://longbridge.com/en/news/293786424.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**